Occidental generated 5423000000 in revenue in Q4 2025 and reported a net loss attributable to common stockholders of 68000000, while producing 1481 Mboed and delivering 2600000000 in operating cash flow and 963000000 in free cash flow before working capital.

Occidental delivered strong operational and financial performance in Q3 2025, supported by high production levels and disciplined capital allocation. The company repaid $1.3 billion in debt and generated $1.5 billion in free cash flow before working capital.

Occidental reported revenue of $6.456 B, EPS of $0.26 (GAAP) and $0.39 (non-GAAP), and net income of $288 M in Q2 2025, supported by $5.108 B of operating cash flow and $696 M of free cash flow before working capital.

Occidental delivered $860 million in adjusted income and $3.0 billion in operating cash flow before working capital. The company achieved mid-point production guidance and beat expectations in its OxyChem and Midstream segments.

Occidental delivered strong operational results with record production of 1,463 Mboed, exceeding guidance. However, a $1.1 billion environmental liability charge led to a net loss of $297 million. Adjusted EPS increased to $0.80, supported by solid oil and gas performance and cash flow. The company met its debt repayment target of $4.5 billion and announced $1.2 billion in divestitures.

Occidental announced strong Q3 2024 results, with net income of $964 million, or $0.98 per diluted share, and adjusted income of $977 million, or $1.00 per diluted share. The company achieved its highest quarterly operating cash flow this year and made significant progress in debt reduction.

Occidental announced strong Q2 2024 results, driven by robust operational performance. The company reported net income of $1.0 billion, or $1.03 per diluted share. Total production exceeded guidance, and Midstream and Marketing outperformed expectations.

Occidental announced strong Q1 2024 results, with operating cash flow of $2.0 billion and free cash flow before working capital of $720 million. The company's total production reached 1,172 Mboed, and OxyChem's pre-tax income exceeded guidance at $260 million. Earnings per diluted share stood at $0.75, while adjusted earnings per diluted share were $0.63.